Inhalation Powder Budesonide Market
1 Study Coverage
1.1 Inhalation Powder Budesonide Product Introduction
1.2 Market by Type
1.2.1 Global Inhalation Powder Budesonide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 100~200 Inhalation
1.2.3 Other
1.3 Market by Application
1.3.1 Global Inhalation Powder Budesonide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Inhalation Powder Budesonide Sales Estimates and Forecasts 2017-2028
2.2 Global Inhalation Powder Budesonide Revenue Estimates and Forecasts 2017-2028
2.3 Global Inhalation Powder Budesonide Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Inhalation Powder Budesonide Sales by Region
2.4.1 Global Inhalation Powder Budesonide Sales by Region (2017-2022)
2.4.2 Global Sales Inhalation Powder Budesonide by Region (2023-2028)
2.5 Global Inhalation Powder Budesonide Revenue by Region
2.5.1 Global Inhalation Powder Budesonide Revenue by Region (2017-2022)
2.5.2 Global Inhalation Powder Budesonide Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Inhalation Powder Budesonide Sales by Manufacturers
3.1.1 Global Top Inhalation Powder Budesonide Manufacturers by Sales (2017-2022)
3.1.2 Global Inhalation Powder Budesonide Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inhalation Powder Budesonide in 2021
3.2 Global Inhalation Powder Budesonide Revenue by Manufacturers
3.2.1 Global Inhalation Powder Budesonide Revenue by Manufacturers (2017-2022)
3.2.2 Global Inhalation Powder Budesonide Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Inhalation Powder Budesonide Revenue in 2021
3.3 Global Inhalation Powder Budesonide Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Inhalation Powder Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Inhalation Powder Budesonide Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Inhalation Powder Budesonide Sales by Type
4.1.1 Global Inhalation Powder Budesonide Historical Sales by Type (2017-2022)
4.1.2 Global Inhalation Powder Budesonide Forecasted Sales by Type (2023-2028)
4.1.3 Global Inhalation Powder Budesonide Sales Market Share by Type (2017-2028)
4.2 Global Inhalation Powder Budesonide Revenue by Type
4.2.1 Global Inhalation Powder Budesonide Historical Revenue by Type (2017-2022)
4.2.2 Global Inhalation Powder Budesonide Forecasted Revenue by Type (2023-2028)
4.2.3 Global Inhalation Powder Budesonide Revenue Market Share by Type (2017-2028)
4.3 Global Inhalation Powder Budesonide Price by Type
4.3.1 Global Inhalation Powder Budesonide Price by Type (2017-2022)
4.3.2 Global Inhalation Powder Budesonide Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Inhalation Powder Budesonide Sales by Application
5.1.1 Global Inhalation Powder Budesonide Historical Sales by Application (2017-2022)
5.1.2 Global Inhalation Powder Budesonide Forecasted Sales by Application (2023-2028)
5.1.3 Global Inhalation Powder Budesonide Sales Market Share by Application (2017-2028)
5.2 Global Inhalation Powder Budesonide Revenue by Application
5.2.1 Global Inhalation Powder Budesonide Historical Revenue by Application (2017-2022)
5.2.2 Global Inhalation Powder Budesonide Forecasted Revenue by Application (2023-2028)
5.2.3 Global Inhalation Powder Budesonide Revenue Market Share by Application (2017-2028)
5.3 Global Inhalation Powder Budesonide Price by Application
5.3.1 Global Inhalation Powder Budesonide Price by Application (2017-2022)
5.3.2 Global Inhalation Powder Budesonide Price Forecast by Application (2023-2028)
6 North America
6.1 North America Inhalation Powder Budesonide Market Size by Type
6.1.1 North America Inhalation Powder Budesonide Sales by Type (2017-2028)
6.1.2 North America Inhalation Powder Budesonide Revenue by Type (2017-2028)
6.2 North America Inhalation Powder Budesonide Market Size by Application
6.2.1 North America Inhalation Powder Budesonide Sales by Application (2017-2028)
6.2.2 North America Inhalation Powder Budesonide Revenue by Application (2017-2028)
6.3 North America Inhalation Powder Budesonide Market Size by Country
6.3.1 North America Inhalation Powder Budesonide Sales by Country (2017-2028)
6.3.2 North America Inhalation Powder Budesonide Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Inhalation Powder Budesonide Market Size by Type
7.1.1 Europe Inhalation Powder Budesonide Sales by Type (2017-2028)
7.1.2 Europe Inhalation Powder Budesonide Revenue by Type (2017-2028)
7.2 Europe Inhalation Powder Budesonide Market Size by Application
7.2.1 Europe Inhalation Powder Budesonide Sales by Application (2017-2028)
7.2.2 Europe Inhalation Powder Budesonide Revenue by Application (2017-2028)
7.3 Europe Inhalation Powder Budesonide Market Size by Country
7.3.1 Europe Inhalation Powder Budesonide Sales by Country (2017-2028)
7.3.2 Europe Inhalation Powder Budesonide Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Inhalation Powder Budesonide Market Size by Type
8.1.1 Asia Pacific Inhalation Powder Budesonide Sales by Type (2017-2028)
8.1.2 Asia Pacific Inhalation Powder Budesonide Revenue by Type (2017-2028)
8.2 Asia Pacific Inhalation Powder Budesonide Market Size by Application
8.2.1 Asia Pacific Inhalation Powder Budesonide Sales by Application (2017-2028)
8.2.2 Asia Pacific Inhalation Powder Budesonide Revenue by Application (2017-2028)
8.3 Asia Pacific Inhalation Powder Budesonide Market Size by Region
8.3.1 Asia Pacific Inhalation Powder Budesonide Sales by Region (2017-2028)
8.3.2 Asia Pacific Inhalation Powder Budesonide Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Inhalation Powder Budesonide Market Size by Type
9.1.1 Latin America Inhalation Powder Budesonide Sales by Type (2017-2028)
9.1.2 Latin America Inhalation Powder Budesonide Revenue by Type (2017-2028)
9.2 Latin America Inhalation Powder Budesonide Market Size by Application
9.2.1 Latin America Inhalation Powder Budesonide Sales by Application (2017-2028)
9.2.2 Latin America Inhalation Powder Budesonide Revenue by Application (2017-2028)
9.3 Latin America Inhalation Powder Budesonide Market Size by Country
9.3.1 Latin America Inhalation Powder Budesonide Sales by Country (2017-2028)
9.3.2 Latin America Inhalation Powder Budesonide Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Inhalation Powder Budesonide Market Size by Type
10.1.1 Middle East and Africa Inhalation Powder Budesonide Sales by Type (2017-2028)
10.1.2 Middle East and Africa Inhalation Powder Budesonide Revenue by Type (2017-2028)
10.2 Middle East and Africa Inhalation Powder Budesonide Market Size by Application
10.2.1 Middle East and Africa Inhalation Powder Budesonide Sales by Application (2017-2028)
10.2.2 Middle East and Africa Inhalation Powder Budesonide Revenue by Application (2017-2028)
10.3 Middle East and Africa Inhalation Powder Budesonide Market Size by Country
10.3.1 Middle East and Africa Inhalation Powder Budesonide Sales by Country (2017-2028)
10.3.2 Middle East and Africa Inhalation Powder Budesonide Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Inhalation Powder Budesonide Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AstraZeneca Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Overview
11.2.3 Teva Inhalation Powder Budesonide Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teva Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Overview
11.3.3 Mylan Inhalation Powder Budesonide Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mylan Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mylan Recent Developments
11.4 Sandoz
11.4.1 Sandoz Corporation Information
11.4.2 Sandoz Overview
11.4.3 Sandoz Inhalation Powder Budesonide Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sandoz Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sandoz Recent Developments
11.5 Cosmo Pharmaceuticals
11.5.1 Cosmo Pharmaceuticals Corporation Information
11.5.2 Cosmo Pharmaceuticals Overview
11.5.3 Cosmo Pharmaceuticals Inhalation Powder Budesonide Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Cosmo Pharmaceuticals Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cosmo Pharmaceuticals Recent Developments
11.6 Salix
11.6.1 Salix Corporation Information
11.6.2 Salix Overview
11.6.3 Salix Inhalation Powder Budesonide Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Salix Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Salix Recent Developments
11.7 Chiesi Farmaceutici
11.7.1 Chiesi Farmaceutici Corporation Information
11.7.2 Chiesi Farmaceutici Overview
11.7.3 Chiesi Farmaceutici Inhalation Powder Budesonide Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Chiesi Farmaceutici Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Chiesi Farmaceutici Recent Developments
11.8 Orion Corporation
11.8.1 Orion Corporation Corporation Information
11.8.2 Orion Corporation Overview
11.8.3 Orion Corporation Inhalation Powder Budesonide Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Orion Corporation Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Orion Corporation Recent Developments
11.9 Cipla
11.9.1 Cipla Corporation Information
11.9.2 Cipla Overview
11.9.3 Cipla Inhalation Powder Budesonide Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Cipla Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Cipla Recent Developments
11.10 Synmosa Biopharma
11.10.1 Synmosa Biopharma Corporation Information
11.10.2 Synmosa Biopharma Overview
11.10.3 Synmosa Biopharma Inhalation Powder Budesonide Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Synmosa Biopharma Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Synmosa Biopharma Recent Developments
11.11 Lunan Better Pharma
11.11.1 Lunan Better Pharma Corporation Information
11.11.2 Lunan Better Pharma Overview
11.11.3 Lunan Better Pharma Inhalation Powder Budesonide Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Lunan Better Pharma Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Lunan Better Pharma Recent Developments
11.12 Shanghai Sine Promod
11.12.1 Shanghai Sine Promod Corporation Information
11.12.2 Shanghai Sine Promod Overview
11.12.3 Shanghai Sine Promod Inhalation Powder Budesonide Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Shanghai Sine Promod Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Shanghai Sine Promod Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Inhalation Powder Budesonide Industry Chain Analysis
12.2 Inhalation Powder Budesonide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inhalation Powder Budesonide Production Mode & Process
12.4 Inhalation Powder Budesonide Sales and Marketing
12.4.1 Inhalation Powder Budesonide Sales Channels
12.4.2 Inhalation Powder Budesonide Distributors
12.5 Inhalation Powder Budesonide Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Inhalation Powder Budesonide Industry Trends
13.2 Inhalation Powder Budesonide Market Drivers
13.3 Inhalation Powder Budesonide Market Challenges
13.4 Inhalation Powder Budesonide Market Restraints
14 Key Findings in The Global Inhalation Powder Budesonide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Inhalation Powder Budesonide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 100~200 Inhalation
Table 3. Major Manufacturers of Other
Table 4. Global Inhalation Powder Budesonide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Inhalation Powder Budesonide Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Inhalation Powder Budesonide Sales by Region (2017-2022) & (K Units)
Table 7. Global Inhalation Powder Budesonide Sales Market Share by Region (2017-2022)
Table 8. Global Inhalation Powder Budesonide Sales by Region (2023-2028) & (K Units)
Table 9. Global Inhalation Powder Budesonide Sales Market Share by Region (2023-2028)
Table 10. Global Inhalation Powder Budesonide Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Inhalation Powder Budesonide Revenue Market Share by Region (2017-2022)
Table 12. Global Inhalation Powder Budesonide Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Inhalation Powder Budesonide Revenue Market Share by Region (2023-2028)
Table 14. Global Inhalation Powder Budesonide Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Inhalation Powder Budesonide Sales Share by Manufacturers (2017-2022)
Table 16. Global Inhalation Powder Budesonide Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Inhalation Powder Budesonide Revenue Share by Manufacturers (2017-2022)
Table 18. Inhalation Powder Budesonide Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Inhalation Powder Budesonide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Inhalation Powder Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalation Powder Budesonide as of 2021)
Table 21. Inhalation Powder Budesonide Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Inhalation Powder Budesonide Product Offered
Table 23. Date of Manufacturers Enter into Inhalation Powder Budesonide Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Inhalation Powder Budesonide Sales by Type (2017-2022) & (K Units)
Table 26. Global Inhalation Powder Budesonide Sales by Type (2023-2028) & (K Units)
Table 27. Global Inhalation Powder Budesonide Sales Share by Type (2017-2022)
Table 28. Global Inhalation Powder Budesonide Sales Share by Type (2023-2028)
Table 29. Global Inhalation Powder Budesonide Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Inhalation Powder Budesonide Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Inhalation Powder Budesonide Revenue Share by Type (2017-2022)
Table 32. Global Inhalation Powder Budesonide Revenue Share by Type (2023-2028)
Table 33. Inhalation Powder Budesonide Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Inhalation Powder Budesonide Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Inhalation Powder Budesonide Sales by Application (2017-2022) & (K Units)
Table 36. Global Inhalation Powder Budesonide Sales by Application (2023-2028) & (K Units)
Table 37. Global Inhalation Powder Budesonide Sales Share by Application (2017-2022)
Table 38. Global Inhalation Powder Budesonide Sales Share by Application (2023-2028)
Table 39. Global Inhalation Powder Budesonide Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Inhalation Powder Budesonide Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Inhalation Powder Budesonide Revenue Share by Application (2017-2022)
Table 42. Global Inhalation Powder Budesonide Revenue Share by Application (2023-2028)
Table 43. Inhalation Powder Budesonide Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Inhalation Powder Budesonide Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Inhalation Powder Budesonide Sales by Type (2017-2022) & (K Units)
Table 46. North America Inhalation Powder Budesonide Sales by Type (2023-2028) & (K Units)
Table 47. North America Inhalation Powder Budesonide Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Inhalation Powder Budesonide Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Inhalation Powder Budesonide Sales by Application (2017-2022) & (K Units)
Table 50. North America Inhalation Powder Budesonide Sales by Application (2023-2028) & (K Units)
Table 51. North America Inhalation Powder Budesonide Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Inhalation Powder Budesonide Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Inhalation Powder Budesonide Sales by Country (2017-2022) & (K Units)
Table 54. North America Inhalation Powder Budesonide Sales by Country (2023-2028) & (K Units)
Table 55. North America Inhalation Powder Budesonide Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Inhalation Powder Budesonide Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Inhalation Powder Budesonide Sales by Type (2017-2022) & (K Units)
Table 58. Europe Inhalation Powder Budesonide Sales by Type (2023-2028) & (K Units)
Table 59. Europe Inhalation Powder Budesonide Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Inhalation Powder Budesonide Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Inhalation Powder Budesonide Sales by Application (2017-2022) & (K Units)
Table 62. Europe Inhalation Powder Budesonide Sales by Application (2023-2028) & (K Units)
Table 63. Europe Inhalation Powder Budesonide Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Inhalation Powder Budesonide Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Inhalation Powder Budesonide Sales by Country (2017-2022) & (K Units)
Table 66. Europe Inhalation Powder Budesonide Sales by Country (2023-2028) & (K Units)
Table 67. Europe Inhalation Powder Budesonide Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Inhalation Powder Budesonide Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Inhalation Powder Budesonide Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Inhalation Powder Budesonide Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Inhalation Powder Budesonide Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Inhalation Powder Budesonide Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Inhalation Powder Budesonide Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Inhalation Powder Budesonide Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Inhalation Powder Budesonide Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Inhalation Powder Budesonide Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Inhalation Powder Budesonide Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Inhalation Powder Budesonide Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Inhalation Powder Budesonide Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Inhalation Powder Budesonide Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Inhalation Powder Budesonide Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Inhalation Powder Budesonide Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Inhalation Powder Budesonide Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Inhalation Powder Budesonide Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Inhalation Powder Budesonide Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Inhalation Powder Budesonide Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Inhalation Powder Budesonide Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Inhalation Powder Budesonide Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Inhalation Powder Budesonide Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Inhalation Powder Budesonide Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Inhalation Powder Budesonide Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Inhalation Powder Budesonide Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Inhalation Powder Budesonide Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Inhalation Powder Budesonide Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Inhalation Powder Budesonide Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Inhalation Powder Budesonide Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Inhalation Powder Budesonide Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Inhalation Powder Budesonide Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Inhalation Powder Budesonide Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Inhalation Powder Budesonide Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Inhalation Powder Budesonide Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Inhalation Powder Budesonide Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Inhalation Powder Budesonide Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Inhalation Powder Budesonide Revenue by Country (2023-2028) & (US$ Million)
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Major Businesses
Table 107. AstraZeneca Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. AstraZeneca Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. AstraZeneca Recent Developments
Table 110. Teva Corporation Information
Table 111. Teva Description and Major Businesses
Table 112. Teva Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Teva Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Teva Recent Developments
Table 115. Mylan Corporation Information
Table 116. Mylan Description and Major Businesses
Table 117. Mylan Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Mylan Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Mylan Recent Developments
Table 120. Sandoz Corporation Information
Table 121. Sandoz Description and Major Businesses
Table 122. Sandoz Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Sandoz Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sandoz Recent Developments
Table 125. Cosmo Pharmaceuticals Corporation Information
Table 126. Cosmo Pharmaceuticals Description and Major Businesses
Table 127. Cosmo Pharmaceuticals Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Cosmo Pharmaceuticals Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Cosmo Pharmaceuticals Recent Developments
Table 130. Salix Corporation Information
Table 131. Salix Description and Major Businesses
Table 132. Salix Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Salix Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Salix Recent Developments
Table 135. Chiesi Farmaceutici Corporation Information
Table 136. Chiesi Farmaceutici Description and Major Businesses
Table 137. Chiesi Farmaceutici Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Chiesi Farmaceutici Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Chiesi Farmaceutici Recent Developments
Table 140. Orion Corporation Corporation Information
Table 141. Orion Corporation Description and Major Businesses
Table 142. Orion Corporation Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Orion Corporation Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Orion Corporation Recent Developments
Table 145. Cipla Corporation Information
Table 146. Cipla Description and Major Businesses
Table 147. Cipla Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Cipla Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Cipla Recent Developments
Table 150. Synmosa Biopharma Corporation Information
Table 151. Synmosa Biopharma Description and Major Businesses
Table 152. Synmosa Biopharma Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Synmosa Biopharma Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Synmosa Biopharma Recent Developments
Table 155. Lunan Better Pharma Corporation Information
Table 156. Lunan Better Pharma Description and Major Businesses
Table 157. Lunan Better Pharma Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Lunan Better Pharma Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Lunan Better Pharma Recent Developments
Table 160. Shanghai Sine Promod Corporation Information
Table 161. Shanghai Sine Promod Description and Major Businesses
Table 162. Shanghai Sine Promod Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Shanghai Sine Promod Inhalation Powder Budesonide Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Shanghai Sine Promod Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Inhalation Powder Budesonide Distributors List
Table 168. Inhalation Powder Budesonide Customers List
Table 169. Inhalation Powder Budesonide Market Trends
Table 170. Inhalation Powder Budesonide Market Drivers
Table 171. Inhalation Powder Budesonide Market Challenges
Table 172. Inhalation Powder Budesonide Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Inhalation Powder Budesonide Product Picture
Figure 3. Global Inhalation Powder Budesonide Market Share by Type in 2021 & 2028
Figure 3. 100~200 Inhalation Product Picture
Figure 4. Other Product Picture
Figure 5. Global Inhalation Powder Budesonide Market Share by Application in 2021 & 2028
Figure 6. Respiratory Disease Treatment
Figure 7. Nose Disease Treatment
Figure 8. Inflammatory Bowel Disease Treatment
Figure 9. Other
Figure 10. Inhalation Powder Budesonide Report Years Considered
Figure 11. Global Inhalation Powder Budesonide Sales 2017-2028 (K Units)
Figure 12. Global Inhalation Powder Budesonide Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Inhalation Powder Budesonide Revenue 2017-2028 (US$ Million)
Figure 14. Global Inhalation Powder Budesonide Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Inhalation Powder Budesonide Sales Market Share by Region (2017-2022)
Figure 16. Global Inhalation Powder Budesonide Sales Market Share by Region (2023-2028)
Figure 17. North America Inhalation Powder Budesonide Sales YoY (2017-2028) & (K Units)
Figure 18. North America Inhalation Powder Budesonide Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Inhalation Powder Budesonide Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Inhalation Powder Budesonide Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Inhalation Powder Budesonide Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Inhalation Powder Budesonide Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Inhalation Powder Budesonide Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Inhalation Powder Budesonide Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Inhalation Powder Budesonide Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Inhalation Powder Budesonide Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Inhalation Powder Budesonide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Inhalation Powder Budesonide in the World: Market Share by Inhalation Powder Budesonide Revenue in 2021
Figure 29. Global Inhalation Powder Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Inhalation Powder Budesonide Sales Market Share by Type (2017-2028)
Figure 31. Global Inhalation Powder Budesonide Revenue Market Share by Type (2017-2028)
Figure 32. Global Inhalation Powder Budesonide Sales Market Share by Application (2017-2028)
Figure 33. Global Inhalation Powder Budesonide Revenue Market Share by Application (2017-2028)
Figure 34. North America Inhalation Powder Budesonide Sales Market Share by Type (2017-2028)
Figure 35. North America Inhalation Powder Budesonide Revenue Market Share by Type (2017-2028)
Figure 36. North America Inhalation Powder Budesonide Sales Market Share by Application (2017-2028)
Figure 37. North America Inhalation Powder Budesonide Revenue Market Share by Application (2017-2028)
Figure 38. North America Inhalation Powder Budesonide Sales Share by Country (2017-2028)
Figure 39. North America Inhalation Powder Budesonide Revenue Share by Country (2017-2028)
Figure 40. U.S. Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Inhalation Powder Budesonide Sales Market Share by Type (2017-2028)
Figure 43. Europe Inhalation Powder Budesonide Revenue Market Share by Type (2017-2028)
Figure 44. Europe Inhalation Powder Budesonide Sales Market Share by Application (2017-2028)
Figure 45. Europe Inhalation Powder Budesonide Revenue Market Share by Application (2017-2028)
Figure 46. Europe Inhalation Powder Budesonide Sales Share by Country (2017-2028)
Figure 47. Europe Inhalation Powder Budesonide Revenue Share by Country (2017-2028)
Figure 48. Germany Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 49. France Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Inhalation Powder Budesonide Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Inhalation Powder Budesonide Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Inhalation Powder Budesonide Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Inhalation Powder Budesonide Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Inhalation Powder Budesonide Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Inhalation Powder Budesonide Revenue Share by Region (2017-2028)
Figure 59. China Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 62. India Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Inhalation Powder Budesonide Sales Market Share by Type (2017-2028)
Figure 69. Latin America Inhalation Powder Budesonide Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Inhalation Powder Budesonide Sales Market Share by Application (2017-2028)
Figure 71. Latin America Inhalation Powder Budesonide Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Inhalation Powder Budesonide Sales Share by Country (2017-2028)
Figure 73. Latin America Inhalation Powder Budesonide Revenue Share by Country (2017-2028)
Figure 74. Mexico Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Inhalation Powder Budesonide Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Inhalation Powder Budesonide Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Inhalation Powder Budesonide Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Inhalation Powder Budesonide Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Inhalation Powder Budesonide Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Inhalation Powder Budesonide Revenue Share by Country (2017-2028)
Figure 83. Turkey Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Inhalation Powder Budesonide Revenue (2017-2028) & (US$ Million)
Figure 86. Inhalation Powder Budesonide Value Chain
Figure 87. Inhalation Powder Budesonide Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Industry Market Size
